Register entryRepackager / relabeller
Assertio Specialty Pharmaceuticals, LLC
- Registered sites
- 3
- Drug products
- 3
- Live patents
- 0
- Countries
- 1
- Base
- United States
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Labelling
Sites
Facilities
3| Site | Location | Operations | FEI |
|---|---|---|---|
| Assertio Specialty Pharmaceuticals, LLC | Lake Forest, ILUnited States | Labelling | 3021594503 |
| Assertio Therapeutics, Inc. | Lake Forest, ILUnited States | Labelling | 3003099171 |
| Zyla Life Sciences US LLC | Lake Forest, ILUnited States | Labelling | 3013684924 |
Catalogue
Marketed products
3Showing 3 of 3.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| Cambia | diclofenac potassium | POWDER, FOR SOLUTION | NDA |
| Rolvedon | eflapegrastim-xnst | INJECTION, SOLUTION | BLA |
| ZIPSOR | diclofenac potassium | CAPSULE, LIQUID FILLED | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.